The stock market extended its winning streak on Wednesday, closing firmer as investors seemed to have already priced in the ...

We recently compiled a list of the Jim Cramer Shed Light on These 8 Stocks Recently. In this article, we are going to take a ...

Shares of Tempus AI (TEM) are down 92c, or 2%, to $49.53 in Thursday morning trading after it was disclosed in a regulatory filing last night that founder and CEO Eric Lefkofsky disposed of ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Tempus AI. Looking at options history for Tempus AI (NASDAQ:TEM) we detected 24 trades. If we consider the specifics ...

Whales with a lot of money to spend have taken a noticeably bearish stance on Tempus AI. Looking at options history for Tempus AI TEM we detected 21 trades. If we consider the specifics of each ...

In a regulatory filing on Friday, Tempus AI (TEM) disclosed that Chairman and CEO Eric Lefkofsky sold a series of shares beginning on January 22, totaling about $62M. On January 22, Lefkofsky sold ...

Tempus AI (NASDAQ: TEM), a healthcare technology company, saw its stock surge 45% in a week after the company announced the launch of its AI app – Olivia. TEM stock was listed on June 14, 2024 ...

For the fourth quarter and full-year 2024, Tempus AI announced its preliminary revenue numbers on Jan. 13. Per the announcement, fourth-quarter preliminary revenues were around $200 million ...

Tempus AI (NASDAQ:TEM) wasn’t that remarkable compared to most other AI high-fliers in the past year. The stock was very volatile in the past year and declined significantly in December 2024 ...

Silverleafe Capital Partners LLC bought a new stake in Tempus AI during the fourth quarter valued at approximately $533,000. Franklin Resources Inc. boosted its stake in shares of Tempus AI by 1.0 ...

CHICAGO, January 15, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the ...

Tempus AI is a leading player in healthcare AI, aiming to deliver personalized treatment suggestions through its proprietary data model. Preliminary Q4 results and 2025 guidance show mixed ...